Heart attack damage slashed with micro particle therapy
First therapy to target damage after heart attack could transform field. After a heart attack, much of the damage to the heart muscle is caused by inflammatory cells… read more.
First therapy to target damage after heart attack could transform field. After a heart attack, much of the damage to the heart muscle is caused by inflammatory cells… read more.
Measuring creatine levels with MRI has benefits over contrast-enhanced MRI and MRS. A new MRI method to map creatine at higher resolutions in the heart may help clinicians… read more.
Exposing skin to sunlight may help to reduce blood pressure and thus cut the risk of heart attack and stroke, a study published in the Journal of Investigative Dermatology suggests.
Researchers in Sweden have found an association between a person’s fitness as a teenager and their risk of heart attack in later life. In a study of nearly… read more.
Researchers found a novel approach to predict outcomes in heart failure patients by imaging impaired energy metabolism in a diseased heart. Researchers have identified a new method to… read more.
Coronary artery calcium testing trumps cholesterol levels, high blood pressure and other risk factors in predicting heart attacks and deaths.
Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to… read more.
Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to… read more.
How do you measure the pain of a patient who can’t communicate? A Rhode Island Hospital researcher studied an observational pain scale in cardiac surgery patients, and found… read more.
by Bruce Sylvester – A routine flu vaccine appears to lower the risk of heart attack or stroke by more than 50 per cent among persons who have… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Anti-clotting agent helps reduce the risk of intraprocedural events during percutaneous coronary intervention.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. In a clinical trial, a self-expanding transcatheter aortic valve met the key… read more.
Advertisment